{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:40:12Z","timestamp":1778931612397,"version":"3.51.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:p>Orexin plays an important role in pain modulation. Orexin-1 and orexin-2 receptors (Ox1r and Ox2r) are found at high density in the ventrolateral periaqueductal gray matter (vlPAG). Our previous study showed that chemical stimulation of the lateral hypothalamus with carbachol induces antinociception in the tail-flick test, a model of acute pain, and Ox1r-mediated antinociception in the vlPAG is modulated by the activity of vlPAG CB1 receptors. In the current study, TCS OX2 29, an Ox2r antagonist (5, 15, 50, 150, and 500\u2009nmol\/l), was microinjected into the vlPAG 5\u2009min before the administration of carbachol (125\u2009nmol\/l). TCS OX2 29 dose dependently reduced carbachol-induced antinociception. In a second set of experiments, animals were treated with carbachol 5\u2009min after intra-vlPAG administration of 15\u2009nmol\/l TCS OX2 29 and 1\u2009nmol\/l AM251 (a selective CB1 receptor antagonist), or 150\u2009nmol\/l TCS OX2 29 and 10\u2009nmol\/l AM251. The findings showed that the antinociceptive effect of orexin is partially mediated by activation of vlPAG Ox2 receptors. Furthermore, the administration of ineffective doses of Ox2 and CB1 receptor antagonists reduced the lateral hypothalamus-induced antinociception. It seems that Ox2 and CB1 receptors act through different pathways and Ox2r-mediated antinociception is not dependent on CB1 receptor activity.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000277","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T16:58:29Z","timestamp":1480525109000},"page":"83-89","source":"Crossref","is-referenced-by-count":15,"title":["Role of orexin-2 and CB1 receptors within the periaqueductal gray matter in lateral hypothalamic-induced antinociception in rats"],"prefix":"10.1097","volume":"28","author":[{"given":"Mohammad-Hossein","family":"Esmaeili","sequence":"first","affiliation":[{"name":"Department of Physiology, Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Reisi","sequence":"additional","affiliation":[{"name":"School of Medicine, Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somayeh","family":"Ezzatpanah","sequence":"additional","affiliation":[{"name":"School of Medicine, Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Haghparast","sequence":"additional","affiliation":[{"name":"School of Medicine, Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neuropharm.2012.04.024","article-title":"CB2 cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons","volume":"63","author":"Atwood","year":"2012","journal-title":"Neuropharmacology"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jpain.2010.09.006","article-title":"Intra-periaqueductal gray matter microinjection of orexin-A decreases formalin-induced nociceptive behaviors in adult male rats","volume":"12","author":"Azhdari-Zarmehri","year":"2011","journal-title":"J Pain"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.08-08-02780.1988","article-title":"Interactions between the lateral hypothalamus and the periaqueductal gray","volume":"8","author":"Behbehani","year":"1988","journal-title":"J Neurosci"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1152\/jn.1983.50.1.192","article-title":"Inhibition of spinal dorsal horn neuronal responses to noxious skin heating by lateral hypothalamic stimulation in the cat","volume":"50","author":"Carstens","year":"1983","journal-title":"J Neurophysiol"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1124\/jpet.103.056663","article-title":"Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain","volume":"307","author":"Cheng","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"R6-20230910","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2011.08.028","article-title":"Analgesic effects of cannabinoid receptor agonist WIN55, 212-2 in the nucleus cuneiformis in animal models of acute and inflammatory pain in rats","volume":"1420","author":"Ebrahimzadeh","year":"2011","journal-title":"Brain Res"},{"key":"R7-20230910","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/ejp.899","article-title":"Functional interaction between orexin-1 and CB1 receptors in the periaqueductal gray matter during antinociception induced by chemical stimulation of the lateral hypothalamus in rats","volume":"20","author":"Esmaeili","year":"2016","journal-title":"Eur J Pain"},{"key":"R8-20230910","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pbb.2014.12.012","article-title":"Chemical stimulation of the lateral hypothalamus by carbachol attenuated the formalin-induced pain behaviors in rats","volume":"129","author":"Ezzatpanah","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ejp.833","article-title":"Differential contribution of orexin receptors within the ventral tegmental area in modulation of persistent inflammatory pain","volume":"20","author":"Ezzatpanah","year":"2016","journal-title":"Eur J Pain"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0091-3022(03)00028-1","article-title":"The orexin\/hypocretin system: a critical regulator of neuroendocrine and autonomic function","volume":"24","author":"Ferguson","year":"2003","journal-title":"Front Neuroendocrinol"},{"key":"R11-20230910","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brainres.2012.06.023","article-title":"Blockade of D1\/D2 dopamine receptors within the nucleus accumbens attenuated the antinociceptive effect of cannabinoid receptor agonist in the basolateral amygdala","volume":"1471","author":"Haghparast","year":"2012","journal-title":"Brain Res"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"14600","DOI":"10.1523\/JNEUROSCI.2671-11.2011","article-title":"Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition","volume":"31","author":"Ho","year":"2011","journal-title":"J Neurosci"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nature03658","article-title":"An endocannabinoid mechanism for stress-induced analgesia","volume":"435","author":"Hohmann","year":"2005","journal-title":"Nature"},{"key":"R15-20230910","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0006-8993(01)02567-7","article-title":"Microinjection of carbachol in the lateral hypothalamus produces opposing actions on nociception mediated by \u03b1 1-and \u03b1 2-adrenoceptors","volume":"911","author":"Holden","year":"2001","journal-title":"Brain Res"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuroscience.2014.04.020","article-title":"Differences in carbachol dose, pain condition, and sex following lateral hypothalamic stimulation","volume":"270","author":"Holden","year":"2014","journal-title":"Neuroscience"},{"key":"R17-20230910","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bbrc.2014.02.026","article-title":"Human orexin\/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors","volume":"445","author":"Jantti","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"R18-20230910","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cellsig.2015.11.009","article-title":"OX2 orexin\/hypocretin receptor signal transduction in recombinant Chinese hamster ovary cells","volume":"28","author":"Kukkonen","year":"2016","journal-title":"Cell Signal"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"C1567","DOI":"10.1152\/ajpcell.00055.2002","article-title":"Functions of the orexinergic\/hypocretinergic system","volume":"283","author":"Kukkonen","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"R20-20230910","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/hbeh.2000.1584","article-title":"Differential distribution and regulation of OX1 and OX2 orexin\/hypocretin receptor messenger RNA in the brain upon fasting","volume":"37","author":"Lu","year":"2000","journal-title":"Horm Behav"},{"issue":"Suppl 1","key":"R21-20230910","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1038\/sj.ijo.0803273","article-title":"Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength","volume":"30","author":"Mackie","year":"2006","journal-title":"Int J Obes"},{"key":"R22-20230910","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1124\/jpet.105.093286","article-title":"Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors","volume":"316","author":"Maione","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"R23-20230910","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cne.1190","article-title":"Differential expression of orexin receptors 1 and 2 in the rat brain","volume":"435","author":"Marcus","year":"2001","journal-title":"J Comp Neurol"},{"key":"R24-20230910","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/26481","article-title":"An analgesia circuit activated by cannabinoids","volume":"395","author":"Meng","year":"1998","journal-title":"Nature"},{"key":"R25-20230910","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0006-8993(89)90461-7","article-title":"Stimulation of the periaqueductal gray matter inhibits nociception at the supraspinal as well as spinal level","volume":"502","author":"Morgan","year":"1989","journal-title":"Brain Res"},{"key":"R26-20230910","first-page":"19","article-title":"Capsazepine, a transient receptor potential vanilloid type 1 (TRPV1) antagonist, attenuates antinociceptive effect of CB1 receptor agonist, WIN55, 212-2, in the rat nucleus cuneiformis","volume":"2","author":"Parvishan","year":"2011","journal-title":"Basic Clin Neurosci"},{"key":"R28-20230910","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"key":"R29-20230910","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"R30-20230910","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2011.03.041","article-title":"Post-ictal analgesia in genetically epilepsy-prone rats is induced by audiogenic seizures and involves cannabinoid receptors in the periaqueductal gray","volume":"1389","author":"Samineni","year":"2011","journal-title":"Brain Res"},{"key":"R31-20230910","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.smrv.2004.07.006","article-title":"Non-sleep effects of hypocretin\/orexin","volume":"9","author":"Samson","year":"2005","journal-title":"Sleep Med Rev"},{"key":"R32-20230910","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.neuropharm.2005.07.007","article-title":"Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla","volume":"49","author":"Suplita","year":"2005","journal-title":"Neuropharmacology"},{"key":"R33-20230910","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pbb.2008.05.010","article-title":"Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures: a short review","volume":"90","author":"Sv\u00ed\u017eensk\u00e1","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"R34-20230910","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0304-3959(87)90039-X","article-title":"Analgesia produced by injection of lidocaine into the lateral hypothalamus","volume":"31","author":"Tasker","year":"1987","journal-title":"Pain"},{"key":"R35-20230910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2014.00057","article-title":"OX1 and OX2 orexin\/hypocretin receptor pharmacogenetics","volume":"8","author":"Thompson","year":"2014","journal-title":"Front Neurosci"},{"key":"R36-20230910","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bjp.0702636","article-title":"Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro","volume":"127","author":"Vaughan","year":"1999","journal-title":"Br J Pharmacol"},{"key":"R37-20230910","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00001756-200501190-00002","article-title":"Persistent pain and stress activate pain-inhibitory orexin pathways","volume":"16","author":"Watanabe","year":"2005","journal-title":"Neuroreport"},{"key":"R38-20230910","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/FBP.0000000000000216","article-title":"Role of orexin-2 receptors in the nucleus accumbens in antinociception induced by carbachol stimulation of the lateral hypothalamus in formalin test","volume":"27","author":"Yazdi","year":"2015","journal-title":"Behav Pharmacol"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201702000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T08:03:36Z","timestamp":1694333016000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201702000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000277","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}